Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Announces Proposals for Structural Healthcare Reform
October 31, 2005
- Opposition from All Stakeholders
October 31, 2005
- Diet Member Starts Discussions on Korosho's Proposals
October 31, 2005
- MOF, Korosho, JMA Debate Korosho's Healthcare Reform Proposals
October 31, 2005
- Opinions Clash over New Prescription Format Proposed by Korosho
October 31, 2005
- PMDA to Give Conditional Approval to More New Drugs: Dr Doi
October 31, 2005
- REGULATORY NEWS IN BRIEF
October 31, 2005
- A Cluster of Diseases - Metabolic Syndrome:Reflecting an Aging Society -2-
October 31, 2005
- Japanese Society of National Medical Service Meets in Hiroshima
October 31, 2005
- MEDICAL DEVICE NEWS IN BRIEF
October 31, 2005
- Chugai Reports Efficacy of Tocilizumab in PIII Study in Japan
October 31, 2005
- York Pharma Lands in Japan
October 31, 2005
- R&D NEWS IN BRIEF
October 31, 2005
- Pfizer Seeks Preliminary Injunction for Return of Data on Amlodipine: DSP
October 31, 2005
- Nihon Medi-Physics Start FDGscan Business in Earnest
October 31, 2005
- SURVEY 3 articles
October 31, 2005
- JPLA LECTURE
October 31, 2005
- Will Gov't Be Able to Stockpile Tamiflu through Public Tender?
October 31, 2005
- PHAEMA DELEGATES
October 31, 2005
- 7th IPLS in Madrid Highlights Importance of Partnering
October 24, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…